Showing 1,241 - 1,260 results of 7,622 for search 'significantly ((((less decrease) OR (((teer decrease) OR (greater decrease))))) OR (we decrease))', query time: 0.50s Refine Results
  1. 1241

    Split structural models for belief. by Abigail A. Lee (19935335)

    Published 2024
    “…<p>Trust in government and positive general vaccine attitudes predicted greater intent to vaccinate. No other latent variables or covariates significantly affected intent to vaccinate. …”
  2. 1242
  3. 1243
  4. 1244

    Phosphorylation as an Effective Tool to Improve Stability and Reduce Toxicity of Antimicrobial Peptides by Zufang Ba (11036420)

    Published 2024
    “…Among them, W<sub>3</sub>BipY<sub>8</sub>-P stood out as the most promising peptide, exhibiting similar antibacterial activity as its unphosphorylated analog W<sub>3</sub>BipY<sub>8</sub> but with significantly reduced hemolytic activity (19-fold decrease), cytotoxicity (3.3-fold decrease), and an extended serum half-life 6.3 times longer than W<sub>3</sub>BipY<sub>8</sub>. …”
  5. 1245

    Volcano plot on differential expression. by Bingshuo Shi (21485387)

    Published 2025
    “…The findings revealed that 5558 genes in total were significantly altered during diapause, with pyruvate kinase (PK), trehalose synthase (TPS), superoxide dismutase (SOD), citrate synthase (CS), and 20-hydroxyecdysone (20E) showing significant decreases. …”
  6. 1246

    Blood Pressure and LDL-C During Follow-up. by Karl Ingard (22582091)

    Published 2025
    “…The risk of cardiovascular death was significantly decreased (HR 0.64, 95% CI 0.41–0.998, <i>P</i> = 0.049) and the risk of fracture non-significantly increased (HR 1.47, 95% CI 0.95–2.27, <i>P</i> = 0.08) in the intervention group compared to the control group.…”
  7. 1247

    Baseline Characteristics of Included Patients. by Karl Ingard (22582091)

    Published 2025
    “…The risk of cardiovascular death was significantly decreased (HR 0.64, 95% CI 0.41–0.998, <i>P</i> = 0.049) and the risk of fracture non-significantly increased (HR 1.47, 95% CI 0.95–2.27, <i>P</i> = 0.08) in the intervention group compared to the control group.…”
  8. 1248

    Variability of gait features during adaptation. by Samantha Jeffcoat (22783930)

    Published 2025
    “…<p>A) We observed significant differences between groups in step length asymmetry variability during EA. …”
  9. 1249

    Data Sheet 1_Statistics and behavior of clinically significant extra-pulmonary vein atrial fibrillation sources: machine-learning-enhanced electrographic flow mapping in persistent... by Peter Ruppersberg (22123543)

    Published 2025
    “…Notably, the majority of significant sources were not continuously active; however, when these sources switched “ON,” the spatial variability of AF cycle lengths in the respective atrium decreased by more than 50%, suggesting an entraining effect.…”
  10. 1250

    Original data2. by Lan Zeng (638254)

    Published 2025
    “…<div><p>Diabetic retinopathy (DR) is a leading cause of blindness. We hypothesised that the long non-coding RNA <i>RP11-502I4.3</i> may be involved in angiogenesis associated with DR. …”
  11. 1251

    Original data1. by Lan Zeng (638254)

    Published 2025
    “…<div><p>Diabetic retinopathy (DR) is a leading cause of blindness. We hypothesised that the long non-coding RNA <i>RP11-502I4.3</i> may be involved in angiogenesis associated with DR. …”
  12. 1252

    Participant demographics. by Anita B. Frohlich (20660615)

    Published 2025
    “…We found that paced nostril breathing both decreased alpha/mu oscillations over central and parietal areas and increased frontal midline and occipital theta oscillations when comparing to spontaneous breathing. …”
  13. 1253

    Theta power for frontal midline ROI. by Anita B. Frohlich (20660615)

    Published 2025
    “…We found that paced nostril breathing both decreased alpha/mu oscillations over central and parietal areas and increased frontal midline and occipital theta oscillations when comparing to spontaneous breathing. …”
  14. 1254

    Variables name and variable measurement. by Jinyuan Li (5927267)

    Published 2025
    “…Using the medical insurance records from 2017 to 2022, we evaluated the impact of the DRG system on medical costs, service efficiency and healthcare quality.…”
  15. 1255

    Chitosan-Based Thermal-Coagulation Hydrogel System Driven by Multiple Interactions: Oxidation-Induced Fast Gelation and Enhanced Performance by Yifan Liu (219681)

    Published 2025
    “…By controlling the grafting rate, it was found that the solution pH and p<i>K</i><sub>a</sub> of CS-C were both affected by the decrease of the amino groups, whereas the gelation time and the required β-GP content for gelling significantly decreased. …”
  16. 1256

    Chitosan-Based Thermal-Coagulation Hydrogel System Driven by Multiple Interactions: Oxidation-Induced Fast Gelation and Enhanced Performance by Yifan Liu (219681)

    Published 2025
    “…By controlling the grafting rate, it was found that the solution pH and p<i>K</i><sub>a</sub> of CS-C were both affected by the decrease of the amino groups, whereas the gelation time and the required β-GP content for gelling significantly decreased. …”
  17. 1257

    Chitosan-Based Thermal-Coagulation Hydrogel System Driven by Multiple Interactions: Oxidation-Induced Fast Gelation and Enhanced Performance by Yifan Liu (219681)

    Published 2025
    “…By controlling the grafting rate, it was found that the solution pH and p<i>K</i><sub>a</sub> of CS-C were both affected by the decrease of the amino groups, whereas the gelation time and the required β-GP content for gelling significantly decreased. …”
  18. 1258
  19. 1259

    The raw data for Fig 4. by Hongjoo An (21703199)

    Published 2025
    “…Luciferase assay and human and mouse brain multi-omics data show that, during the differentiation of OL precursor cells (OPCs) into OLs, the enhancer activity of Sox10-E1 does not change while that of Sox10-E2 decreases significantly. Chromatin interaction data indicate that the two <i>Sox10</i> enhancers lie close to the border of the <i>Sox10</i> topologically associating domain (TAD). …”
  20. 1260

    The raw data for S2 Fig. by Hongjoo An (21703199)

    Published 2025
    “…Luciferase assay and human and mouse brain multi-omics data show that, during the differentiation of OL precursor cells (OPCs) into OLs, the enhancer activity of Sox10-E1 does not change while that of Sox10-E2 decreases significantly. Chromatin interaction data indicate that the two <i>Sox10</i> enhancers lie close to the border of the <i>Sox10</i> topologically associating domain (TAD). …”